Pic Therapeutics reported raising $6.48 Million in an initial SEC Form D filing, from an offering of $35 Million
PRIVATEOct 20, 2022$6.5M of $35M raised
Amount Raised
$6.48 Million
$6.48 Million sold, per SEC Form D (first sale Oct 7, 2022)
Round Type
Venture
NatickBiotechnology
Quick answer
Pic Therapeutics raised $6.48 Million in a funding round, dated October 7, 2022. Pic Therapeutics is based in Natick, Massachusetts, United States.
How much did Pic Therapeutics raise?
Pic Therapeutics raised $6.48 Million in a funding round on October 7, 2022.
What does Pic Therapeutics do?
PIC Therapeutics is a biotechnology company focused on fundamentally changing how we treat cancer by developing a new generation of therapeutics based on the modulation of RNA translation.
Where is Pic Therapeutics based and how big is it?
Pic Therapeutics is based in Natick, Massachusetts, United States.
Source: Fundz verified event record.
Who to call at Pic Therapeutics, and when
A new round usually means Pic Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Pic Therapeutics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Pic Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pic Therapeutics. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Pic Therapeutics
Location
22 Strathmore Road
Natick, Massachusetts, United States
About
PIC Therapeutics is a biotechnology company focused on fundamentally changing how we treat cancer by developing a new generation of therapeutics based on the modulation of RNA translation.
PIC Therapeutics was founded on the seminal work of Dr. Gerhard Wagner, a professor at Harvard Medical School world-renowned for his scientific expertise in protein structure and his research on interactions of eukaryotic translation initiation factors (eIFs).
PIC Therapeutics, led by President and CEO Dr. Kathy Bowdish, was launched to translate these discoveries into small molecule precision therapeutics to benefit cancer patients.
Our precision-based therapeutics target the “master switch” of cancer signaling pathways, selectively blocking oncogene protein production by modulating the Pre-Initiation Complex (PIC) that drives their mRNA translation. Our selective approach has the potential to simultaneously modulate multiple oncogenic drivers leading to a powerful new generation of cancer-treating therapeutics.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Pic Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.